Serum hepcidin levels are innately low in HFE‐related haemochromatosis but differ between C282Y‐homozygotes with elevated and normal ferritin levels
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary: HFE C282Y‐homozygosity has been associated with low hepcidin expression, leading to increased ferritin levels. However, serum hepcidin protein levels have not been documented in humans. In the current study, we compared serum hepcidin levels of newly diagnosed HFE C282Y‐homozygotes with (N = 15) and without (N = 7) elevated serum ferritin levels to levels of 40 controls (20 heterozygotes and 20 wild types). In addition, hepcidin levels of four C282Y homozygotes were investigated during the course of all phlebotomy treatment phases. Serum hepcidin levels were lower in HFE C282Y‐homozygotes (median; 25th–75th percentile: 1·88; 0·78–2·77 nmol/l) compared to controls (2·74; 1·45–5·39). Hepcidin/ferritin ratios were also lower in homozygotes. Homozygotes with an elevated serum ferritin had a higher serum hepcidin but a lower hepcidin/ferritin ratio than those with normal ferritin (2·28; 1·62–3·23 nmol/l hepcidin vs. 0·80; 0·60–1·29 and 3·63; 2·72–7·59 pmol hepcidin/μg ferritin vs. 13·2; 5·15–14·2). Serum hepcidin decreased during the depletion phase of phlebotomy and remained low during maintenance. This study showed that serum hepcidin is innately low in HFE‐related haemochromatosis. Elevated ferritin levels were associated with increased hepcidin levels while erythropoiesis lead to lower hepcidin levels. During depletion, therefore, hepcidin levels are decreased, which may exacerbate intestinal iron absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 2×
“Hepcidin is a small protein that plays an important role in the regulation of systemic iron homeostasis by directing the intestinal absorption and macrophage release of iron via interaction with the sole cellular iron exporter ferroportin (Nemeth et al, 2004; Ganz, 2006).”
BackgroundPigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“This explanation is supported by studies in mice with non-functional HFE-protein where HAMP expression significantly increased upon iron loading (Pigeon et al, 2001; Ahmad et al, 2002).”
ResultNicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214 · cited 1×
“Furthermore, Hamp mRNA expression was suppressed in wild type mice after phlebotomy (Nicolas et al, 2002; Pak et al, 2006) or erythropoietin administration (Pak et al, 2006; Vokurka et al, 2006); this suppression could be reversed by inhibitors of erythropoiesis (Pak et al, 2006; Vokurka et al,…”
BackgroundPenetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J., & Gelbart, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07447-0 · Cited by 823 · cited 1×
“Recent surveys involving HFE-genotyping of non-clinically selected populations found that not all C282Yhomozygotes had iron overload and that most symptoms of disease did not differ between homozygotes and controls [(Allen et al, 2008; Beutler et al, 2002); reviewed by Waalen et al, 2005].”
BackgroundSuppression of hepcidin during anemia requires erythropoietic activity
Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472 · cited 2×
“Furthermore, Hamp mRNA expression was suppressed in wild type mice after phlebotomy (Nicolas et al, 2002; Pak et al, 2006) or erythropoietin administration (Pak et al, 2006; Vokurka et al, 2006); this suppression could be reversed by inhibitors of erythropoiesis (Pak et al, 2006; Vokurka et al,…”
BackgroundLiver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365
Rivera, S., Nemeth, E., Gabayan, V., Lopez, M. A., Farshidi, D., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2005-04-1766 · Cited by 308 · cited 1×
“To date, data on serum hepcidin levels in humans are lacking, even though these levels are directly responsible for the biological effect (Nemeth et al, 2004; Rivera et al, 2005).”
BackgroundUrinary hepcidin in congenital chronic anemias
Kearney, S. L., Nemeth, E., Neufeld, E. J., Thapa, D., Ganz, T., Weinstein, D. A., & Cunningham, M. J. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20616 · Cited by 172 · cited 1×
“Corroborating evidence for a hepcidin lowering effect of increased erythropoiesis comes from human studies on patients with thalassaemia (Kattamis et al, 2006; Kemna et al, 2008; Origa et al, 2007) and haemolytic anaemia (Kearney et al, 2007).”
BackgroundJacobs, E. M. G., Hendriks, J. C. M., van Tits, B. L. J. H., Evans, P. J., Breuer, W., Liu, D. Y., Jansen, E. H. J. M., Jauhiainen, K., Sturm, B., Porter, J. B., et al. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.03.008 · Cited by 101 · cited 1×
“Serum non-transferrin bound iron (NTBI) levels were analyzed by a method based on iron mobilization and detection with iron chelators (Breuer & Cabantchik, 2001; Jacobs et al, 2005).”
MethodSelf-citation
Cited by
Mechanisms of mammalian iron homeostasis
Pantopoulos, K., Porwal, S. K., Tartakoff, A., & Devireddy, L. (2012) · Biochemistry · doi:10.1021/bi300752r · Cited by 598
Regulation of iron transport and the role of transferrin
Gkouvatsos, K., Papanikolaou, G., & Pantopoulos, K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.013 · Cited by 518
Hepcidin in the diagnosis of iron disorders
Girelli, D., Nemeth, E., & Swinkels, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-639112 · Cited by 417
Self-citationHepcidin in Human Iron Disorders: Diagnostic Implications
Kroot, J. J., Tjalsma, H., Fleming, R. E., & Swinkels, D. W. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2009.140053 · Cited by 246
Self-citationTraglia, M., Girelli, D., Biino, G., Campostrini, N., Corbella, M., Sala, C., Masciullo, C., Viganò, F., Buetti, I., Pistis, G., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100061 · Cited by 97
Metadata
- Authors
- Van Dijk, B. A. C., Laarakkers, C. M. M., Klaver, S. M., Jacobs, E. M. G., Van Tits, L. J. H., Janssen, M. C. H., & Swinkels, D. W.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2008-08-21
- Volume
- 142
- Issue
- 6
- Pages
- 979-985
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2011115926
- Cited by
- 95
- References
- 10
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum hepcidin levels are innately low in HFE‐related haemochromatosis but differ between C282Y‐homozygotes with elevated and normal ferritin levels. https://app.cochat.ai/papers/10.1111/j.1365-2141.2008.07273.x
- The paper
- Van Dijk, B. A. C., Laarakkers, C. M. M., Klaver, S. M., Jacobs, E. M. G., Van Tits, L. J. H., Janssen, M. C. H., & Swinkels, D. W. (2008). Serum hepcidin levels are innately low in HFE‐related haemochromatosis but differ between C282Y‐homozygotes with elevated and normal ferritin levels. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2008.07273.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.